Does intravitreal injections of bevacizumab for age-related macular degeneration affect long-term intraocular pressure? [electronic resource]
Producer: 20150324Description: 446-8 p. digitalISSN:- 1536-481X
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Bevacizumab
- Female
- Humans
- Intraocular Pressure -- drug effects
- Intravitreal Injections
- Macular Degeneration -- drug therapy
- Male
- Middle Aged
- Retrospective Studies
- Tonometry, Ocular
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.